Journal article Open Access

ASSESSMENT OF THE IMPACT OF MEDICATION COUNSELLING ON KDQOL SCORE OF PATIENTS WITH CHRONIC KIDNEY DISEASES

Fatima Unnisa, Niyati Kandikanti, Kadam Sushmitha, Parsanaboina Sridivya, Syed Alamdar Shariyar


DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="DOI">10.5281/zenodo.5654815</identifier>
  <creators>
    <creator>
      <creatorName>Fatima Unnisa, Niyati Kandikanti, Kadam Sushmitha, Parsanaboina Sridivya,  Syed Alamdar Shariyar</creatorName>
    </creator>
  </creators>
  <titles>
    <title>ASSESSMENT OF THE IMPACT OF MEDICATION COUNSELLING ON KDQOL SCORE OF PATIENTS WITH CHRONIC KIDNEY DISEASES</title>
  </titles>
  <publisher>Zenodo</publisher>
  <publicationYear>2021</publicationYear>
  <dates>
    <date dateType="Issued">2021-11-08</date>
  </dates>
  <resourceType resourceTypeGeneral="JournalArticle"/>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/5654815</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.5654814</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;&lt;strong&gt;&lt;em&gt;Background&lt;/em&gt;&lt;/strong&gt;&lt;em&gt;: Chronic Kidney Disease (CKD) is a serious medical and public health problem whose prevalence is increasing worldwide. CKD patients are medically complex, require multiple medications for treatments of their various comorbidities, thus these patients are at risk of drug-related problems (DRPs) that may lead to increased morbidity, mortality, and cost to the healthcare system. &lt;strong&gt;Methodology&lt;/strong&gt;: This study was a Prospective, Observational Study carried out for a period of six months in tertiary care hospital to assess the impact of medication counselling on the KDQOL of chronic kidney patients. A total of 32 patients undergoing hemodialysis were enrolled into the study who were categorized into test and control groups by randomize method. Patients in the test group received counselling verbally along with the information leaflet, whereas the control group received the counselling only after the end of the study. The QoL of patients were assessed by using Kidney Disease Quality of Life-36 (KDQOL-36) questionnaire at the baseline and at final follow-up. &lt;strong&gt;Result&lt;/strong&gt;: A statistically significant difference in the domain 4(p&amp;lt; 0.00015)) and domain 5(p&amp;lt;0.000278) was found at 2&lt;sup&gt;nd&lt;/sup&gt; follow up period in test group and in contrast, no significant improvement in control group. The impact of pharmacist&amp;rsquo;s medication counselling on QOL in hemodialysis patients had showed&amp;nbsp;&amp;nbsp; significant improvement.in test group compare to control group. &lt;strong&gt;Conclusion&lt;/strong&gt;: The study suggests that the periodic counselling by a clinical pharmacist at regular intervals has a positive impact on improving the QOL of hemodialysis patients.&lt;/em&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;&lt;em&gt;Keywords&lt;/em&gt;&lt;/strong&gt;&lt;em&gt;: Chronic Kidney Disease, Medication Counselling, KDQOL&lt;/em&gt;&lt;/p&gt;</description>
  </descriptions>
</resource>
58
40
views
downloads
All versions This version
Views 5858
Downloads 4040
Data volume 38.6 MB38.6 MB
Unique views 5757
Unique downloads 3939

Share

Cite as